A citation-based method for searching scientific literature

D M Nathan, S Genuth, J Lachin, P Cleary, O Crofford, M Davis, L Rand, C Siebert. N. Engl. J. Med. 1993
Times Cited: 13053







List of co-cited articles
345 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease.
Christine Bernsmeier, Anne C Meyer-Gerspach, Lea S Blaser, Lia Jeker, Robert E Steinert, Markus H Heim, Christoph Beglinger. PLoS ONE 2014
48
2

Liver transplantation and diabetes mellitus.
T H Steinmüller, M Stockmann, W O Bechstein, U Settmacher, S Jonas, P Neuhaus. Exp. Clin. Endocrinol. Diabetes 2000
36
2

Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor.
D Ish-Shalom, C T Christoffersen, P Vorwerk, N Sacerdoti-Sierra, R M Shymko, D Naor, P De Meyts. Diabetologia 1997
121
1

Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture.
J R Gavin, J Roth, D M Neville, P de Meyts, D N Buell. Proc. Natl. Acad. Sci. U.S.A. 1974
497
1

Hepatitis C virus infection and human pancreatic beta-cell dysfunction.
Matilde Masini, Daniela Campani, Ugo Boggi, Michele Menicagli, Nicola Funel, Maria Pollera, Roberto Lupi, Silvia Del Guerra, Marco Bugliani, Scilla Torri,[...]. Diabetes Care 2005
66
1

Managing diabetes in patients with chronic liver disease.
Roaid Khan, Graham R Foster, Tahseen A Chowdhury. Postgrad Med 2012
16
6

Composition of insulin-induced body weight gain in diabetic patients: a bio-impedance study.
V Rigalleau, C Delafaye, L Baillet, V Vergnot, P Brunou, B Gatta, H Gin. Diabetes Metab. 1999
14
7


Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction.
Manal M Hassan, Ahmed Kaseb, Carol J Etzel, Hashem El-Serag, Margaret R Spitz, Ping Chang, Katherine S Hale, Mei Liu, Asif Rashid, Mohamed Shama,[...]. Mol. Carcinog. 2013
35
2


Hemoglobin A1c Has Suboptimal Performance to Diagnose and Monitor Diabetes Mellitus in Patients with Cirrhosis.
Naga S Addepally, Nayana George, Roberto Martinez-Macias, Mauricio Garcia-Saenz-de-Sicilia, W Ray Kim, Andres Duarte-Rojo. Dig. Dis. Sci. 2018
2
50

Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
M Prashanth, H K Ganesh, M V Vima, M John, T Bandgar, Shashank R Joshi, S R Shah, P M Rathi, A S Joshi, Hemangini Thakkar,[...]. J Assoc Physicians India 2009
85
1

The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice.
Takayasu Ideta, Yohei Shirakami, Tsuneyuki Miyazaki, Takahiro Kochi, Hiroyasu Sakai, Hisataka Moriwaki, Masahito Shimizu. Int J Mol Sci 2015
17
5

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma.
Manal M Hassan, Steven A Curley, Donghui Li, Ahmed Kaseb, Marta Davila, Eddie K Abdalla, Milind Javle, Dalia M Moghazy, Richard D Lozano, James L Abbruzzese,[...]. Cancer 2010
179
1




[Clinical evaluation of serum 1,5AG levels in patients with liver cirrhosis].
M Shibayama, N Oba, Y Senda, M Nishibu, T Hashimoto. Rinsho Byori 1997
4
25

Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines.
Li Kang, Becky M Sebastian, Michele T Pritchard, Brian T Pratt, Stephen F Previs, Laura E Nagy. Alcohol. Clin. Exp. Res. 2007
66
1

Effect of diabetes mellitus on hepatic resection.
K Yanaga, T Matsumata, H Hayashi, M Shimada, K Urata, T Suehiro, K Sugimachi. Arch Surg 1993
29
3

Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.
Jinhua Yan, Bin Yao, Hongyu Kuang, Xubin Yang, Qin Huang, Tianpei Hong, Yushu Li, Jingtao Dou, Wenying Yang, Guijun Qin,[...]. Hepatology 2019
21
4


Managing diabetes and liver disease association: Practice guidelines from the Egyptian Association for the Study of Liver and Gastrointestinal Disease (EASLGD).
Abd Elkhalek Hamed, Medhat Elsahar, Nadia M Elwan, Sarah El-Nakeep, Mervat Naguib, Hanan Hamed Soliman, Ashraf Ahmed Aboubakr, Amany AbdelMaqsod, Heba Sedrak, Samir N Assaad,[...]. Arab J Gastroenterol 2019
1
100

Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance.
Minoru Itou, Takumi Kawaguchi, Eitaro Taniguchi, Shuji Sumie, Tetsuharu Oriishi, Keiichi Mitsuyama, Osamu Tsuruta, Takato Ueno, Michio Sata. J. Gastroenterol. Hepatol. 2008
34
2

Pharmacokinetics of Single-dose Ertugliflozin in Patients With Hepatic Impairment.
Vaishali Sahasrabudhe, Steven G Terra, Anne Hickman, Didier Saur, Sangeeta Raje, Haihong Shi, Kyle Matschke, Susan Zhou, David L Cutler. Clin Ther 2018
6
16

Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.
Jeffrey Cui, Len Philo, Phirum Nguyen, Heather Hofflich, Carolyn Hernandez, Ricki Bettencourt, Lisa Richards, Joanie Salotti, Archana Bhatt, Jonathan Hooker,[...]. J. Hepatol. 2016
122
1

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.
Valter Donadon, Massimiliano Balbi, Maria Dal Mas, Pietro Casarin, Giorgio Zanette. Liver Int. 2010
160
1


Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation.
Uwe J F Tietge, Oliver Selberg, Andreas Kreter, Matthias J Bahr, Matthias Pirlich, Wolfgang Burchert, Manfred J Müller, Michael P Manns, Klaus H W Böker. Liver Transpl. 2004
30
3


Insulin resistance induced by hyperinsulinemia coincides with a persistent alteration at the insulin receptor tyrosine kinase domain.
Karyn J Catalano, Betty A Maddux, Jaroslaw Szary, Jack F Youngren, Ira D Goldfine, Fred Schaufele. PLoS ONE 2014
28
3

Effects of dietary carbohydrate on 1,5-anhydroglucitol in a population without diabetes: results from the OmniCarb trial.
S P Juraschek, E R Miller, L J Appel, R H Christenson, F M Sacks, E Selvin. Diabet. Med. 2017
9
11

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.
Renata Belfort, Stephen A Harrison, Kenneth Brown, Celia Darland, Joan Finch, Jean Hardies, Bogdan Balas, Amalia Gastaldelli, Fermin Tio, Joseph Pulcini,[...]. N. Engl. J. Med. 2006
955
1

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial.
S Nair, A M Diehl, M Wiseman, G H Farr, R P Perrillo. Aliment. Pharmacol. Ther. 2004
210
1

Serum 1,5-anhydroglucitol level as a screening tool for diabetes mellitus in a community-based population at high risk of diabetes.
Yao Wang, Yuexing Yuan, Yanli Zhang, Chenghao Lei, Yi Zhou, Jiajia He, Zilin Sun. Acta Diabetol 2017
14
7

Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial.
Vlad Ratziu, Fréderic Charlotte, Carole Bernhardt, Philippe Giral, Marine Halbron, Gilles Lenaour, Agnès Hartmann-Heurtier, Eric Bruckert, Thierry Poynard. Hepatology 2010
200
1

Posttransplant metabolic syndrome: an epidemic waiting to happen.
Mangesh Pagadala, Srinivasan Dasarathy, Bijan Eghtesad, Arthur J McCullough. Liver Transpl. 2009
93
1

In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy.
Ingrid J Hickman, Elizabeth E Powell, Johannes B Prins, Andrew D Clouston, Susan Ash, David M Purdie, Julie R Jonsson. J. Hepatol. 2003
116
1


Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial.
Tisha R Joy, Charles A McKenzie, Rommel G Tirona, Kelly Summers, Shannon Seney, Subrata Chakrabarti, Neel Malhotra, Melanie D Beaton. World J. Gastroenterol. 2017
41
2

Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3.
Takumi Kawaguchi, Takafumi Yoshida, Masaru Harada, Takao Hisamoto, Yumiko Nagao, Tatsuya Ide, Eitaro Taniguchi, Hiroto Kumemura, Shinichiro Hanada, Michiko Maeyama,[...]. Am. J. Pathol. 2004
374
1

Cytokines and HCV-related autoimmune disorders.
Alessandro Antonelli, Silvia Martina Ferrari, Ilaria Ruffilli, Poupak Fallahi. Immunol. Res. 2014
13
7

Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes.
Fernando Bril, Srilaxmi Kalavalapalli, Virginia C Clark, Romina Lomonaco, Consuelo Soldevila-Pico, I-Chia Liu, Beverly Orsak, Fermin Tio, Kenneth Cusi. Clin. Gastroenterol. Hepatol. 2018
40
2

Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys.
Morgane Thomsen, Jens Juul Holst, Anna Molander, Kristian Linnet, Maurice Ptito, Anders Fink-Jensen. Psychopharmacology (Berl.) 2019
8
12

Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes.
Junichi Matsubara, Seigo Sugiyama, Eiichi Akiyama, Satomi Iwashita, Hirofumi Kurokawa, Keisuke Ohba, Hirofumi Maeda, Koichiro Fujisue, Eiichiro Yamamoto, Koichi Kaikita,[...]. Circ. J. 2013
128
1


A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma.
Jae Uk Shin, Kwang Min Kim, Sung Wook Shin, Shin Young Min, Sang Un Park, Dong Hyun Sinn, Geum Youn Gwak, Moon Seok Choi, Joon Hyoek Lee, Seung Woon Paik,[...]. Dig Liver Dis 2014
7
14

Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events.
Marie Laryea, Kymberly D Watt, Michele Molinari, Mark J Walsh, Vivian C McAlister, Paul J Marotta, Bjorn Nashan, Kevork M Peltekian. Liver Transpl. 2007
165
1

Corrected Fructosamine improves both correlation with HbA1C and diagnostic performance.
S Rodríguez-Segade, J Rodríguez, F Camiña. Clin. Biochem. 2017
8
12

Influence of hepatic impairment on the pharmacokinetics and safety profile of dapagliflozin: an open-label, parallel-group, single-dose study.
Sreeneeranj Kasichayanula, Xiaoni Liu, Weijiang Zhang, Marc Pfister, Frank P LaCreta, David W Boulton. Clin Ther 2011
39
2


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.